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BehaviorThe Keystone SymposiumonNeuroepigenetics (Santa Fe, NM, USA, February 22–26, 2015) brought together
outstanding researchers to discuss their latestﬁndings in theﬁeld of epigenetic regulation of gene expression
in the nervous system. This has been the ﬁrst conference entirely devoted to the integration of the ﬁelds of
epigenetics and neuroscience. The goal of the symposium was to raise new challenging questions and to
stimulate innovative ideas fostered by the provocative results presented by experts working in a wide
array of epigenetic systems and generated by a variety of experimental approaches inmany model systems.
This report will discuss a number of groundbreaking discoveries presented at the symposium encompassing
studies of human evolution, nervous system development, adult brain plasticity, transgenerational inheri-
tance, mental disorders, and large-scale efforts to generate detailed reference epigenomes. The outcome of
the symposium provided new exciting perspectives and the framework for expanding the frontiers of
neuroscience research.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
In recent years, epigenetics has emerged as one of themost rapid-
ly expanding and dynamic research areas in biology that investigates
the genome function in the regulation of an impressive diversity of
cellular processes in homeostasis and disease (Sweatt, 2013). Al-
though the genomic sequence of many organisms has been complet-
ed, understanding howDNA sequences are deciphered in the context
of individual cell types or speciﬁc environmental conditions repre-
sents the fundamental question of epigenetics. Tremendous advances
in massively parallel sequencing techniques have revolutionized the
ﬁeld of epigenetics, and large-scale epigenomic projects, such as the
Encyclopedia of DNA Elements (Stamatoyannopoulos, 2012) and
the NIH Epigenomic Roadmap (Bernstein et al., 2010), have been in-
strumental in identifying the functional elements of the genome and
their contribution to human diseases by generating detailed maps of
chromatin states of distinct cell types and tissues. Because epigenetic
mechanisms play central roles in many neuronal processes, a
deeper understanding of distinct epigenetic signatures of the neu-
ronal genome also has the potential to tackle their deregulation
into a broad spectrum of brain diseases (Telese et al., 2013).
These and other aspects of epigenetics research were addressed at
the Keystone Symposia on Neuroepigenetics. The conference fea-
tured a diverse group of outstanding scientists, including plenary
speakers and junior researchers, reporting their latest ﬁndingsc. This is an open access article unduring an exciting 3-day agenda. The symposia was a tremendous
success supported by NIH Director's Fund and organized by
Hongjun Song (Johns Hopkins University, USA) and Li-Huei Tsai
(Massachusetts Institute of Technology, USA); the program that these
2 leading researchers developed and their selection of presenters
were key to meet the goal of pushing the boundaries in the emerging
ﬁeld of neuroepigenetics.
Keynote session
Two leading pioneers of the ﬁeld delivered the ﬁrst keynote ses-
sion: Fred H. Gage (The Salk Institute for Biological Studies, USA)
and Micheal E. Greenberg (Harvard Medical School, USA). Fred
Gage described his journey in studying the role of transposable ele-
ments in human evolution by identifying the molecular differences
between human and nonhuman primates based on cutting-edge
techniques that incorporate high-throughput sequencing
epigenomic approaches with the establishment of induced pluripo-
tent stem cells (iPSCs) from human, chimpanzee, and bonobo. Com-
parative gene expression analysis of specie-speciﬁc iPSCs revealed
differences in the regulation of long interspersed element 1 (LINE-
1) transposons, which are the only known active transposons in the
human genome (Marchetto et al., 2013). Recent ﬁndings from Gage's
laboratory and others indicated that those elements are expressed
not only in the germ line but also in the brain, challenging the
dogma that the genome of postmitotic neurons is static and suggest-
ing that they drive genetic heterogeneity across neurons in the sameder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ual behavior and contributing to vulnerability to disease (Guffanti
et al., 2014; Kazazian, 2004; Muotri et al., 2005). In his inspiring
talk, Fred Gage presented sequencing data to identify novel
nonreference L1 insertions and provided evidence that LINE-1 repeats
exhibit different mobility in nonprimate compared to humans,
supporting the hypothesis that LINE-1 transposition could be consid-
ered as potential driver of genomic innovation underlying adaptive
changes in evolution. Given that epigenetic mechanisms, such as
DNA methylation, are crucial to control the mobilization of transpos-
able elements in the genome, the study of epigenetic regulation of
their mobility has major implications in all areas of neuroscience
(Erwin et al., 2014).
The second lecture by Michael Greenberg focused on his career-
long research interest regarding the function of gene expression pro-
grams activated by neuronal activity at the level of synapses and
transduced into the nucleus by signaling molecules that ultimately
target transcription factors and chromatin regulators (West and
Greenberg, 2011). The most intriguing aspect of his presentation
was his recent work on the misregulation of long gene expression
in the brain when MECP2 is mutated in human or mouse models of
Rett syndrome (Gabel et al., 2015). Combining genomic proﬁling of
MeCP2 and genome-wide base pair resolution DNA methylation as-
says, it emerged that MECP2 represses long genes by binding to a
form of methylated DNA enriched in the brain. Because the long
genes repressed by MeCP2 are enriched in functional annotation of
neuronal functions, Michael Greenberg proposed the idea that dis-
ruption of long gene expression might be a general mechanism un-
derlying the neurological dysfunctions in Rett syndrome. It was
exciting to hear how the inhibition of topoisomerases with
topotecan, a drug commonly used as a chemotherapeutic agent,
leads to a dose-dependent reversal of long gene expression, which
inspired novel ideas for developing methods to rebalance long
gene expression as a strategy to correct neural dysfunction in
neurodevelopmental disorders.Epigenetic mechanisms in reprogramming
Induced pluripotent stem cell technology represents one of
the major advances in modeling of neurological disorders
in vitro (Nityanandam and Baldwin, 2015). iPSC-derived neurons
represent a powerful strategy for elucidating disease pathogene-
sis for drug discovery and development, for personalized medi-
cine, and eventually for regenerative cell therapy, as suggested
by many talks and posters presented at this meeting. However,
the standard transdifferentiation protocol, which relies on the
forced expression of neural lineage–speciﬁc transcription factors,
is a long process with multiple steps that might increase the het-
erogeneity of the ﬁnal neuronal population. In this context, Xiang-
Dong Fu (University of California, San Diego, CA, USA), a leader in
the research area of RNA splicing, presented his recent work on an
innovative and fast method for direct conversion of somatic cells
to functional neurons based on repressing the expression of a single
RNA binding protein, PTB (Xue et al., 2013). Researchers led by
Xiang-Dong Fu elucidated the molecular feedback loops that modu-
late the repression of PTB during neuronal differentiation when a
microRNA-regulated splicing event causes the switch to the
neuronal-speciﬁc isoform of PTB.
Many discussions at this meeting pivoted on the urgent need of
efﬁcient protocols for transdifferentiation to speciﬁc neuronal sub-
types and supported the notion that the epigenomic proﬁling of
these cells is a crucial strategy for mechanistic characterization of
these cells and for developing novel protocols.Epigeneticmechanisms in regulating synapse formation, plasticity,
and behavior
Long-standing themes such as regulation of synaptic plasticity
were included in the program, and various talks proposed novel view-
points in themolecularmechanisms underlying cognitive functions. A
novel perspective was offered by Li-Huei Tsai, who has dedicated her
career to elucidate molecular and cellular mechanisms of cognition
with particular emphasis on models of Alzheimer disease. She pre-
sented her latest ﬁndings in the regulation of immediate early genes,
which involves generation of DNA double strand breaks within their
promoters to relieve a topological constraint that imposes another
layer of regulation in the fast response of neurons to experience-
dependent changes. This provocative ﬁnding inspired questions re-
garding mechanisms of DNA repair in postmitotic neurons and might
have major implications in the study of neurodegenerative pathways.
David Sweatt (University of Alabama at Birmingham, USA) pre-
sented his recentwork on novelmechanisms of epigenetic regulation
of associative conditioning that involve recently identiﬁed
extracoding RNAs, suggesting that neuronal activity-dependent tran-
scription modulates DNA methylation (Di Ruscio et al., 2013). Those
noncoding RNA molecules are generated from coding genes and
have the ability to block DNA methylation events by forming second-
ary structures that interact with the methyltransferase DNMT1. By
using deep sequencing approaches to proﬁle the transcriptome and
methylome of neuronal cultures, it emerged that the presence of
extracoding RNAs may predict gene-speciﬁc methylation status. This
epigenetic mechanism is involved in the regulation of associative con-
ditioning in the hippocampus, as demonstrated by altered learningbe-
haviors of mice previously injected with antisense oligos interfering
with speciﬁc extracoding RNAs.
In addition, this session highlighted novel groundbreaking dis-
coveries in the epigenetic regulation of synaptic and behavioral
plasticity mediated by methylation events that dynamically target
both DNA and RNA. Particularly, Hongjun Song covered the mech-
anisms of neuronal activity-induced active DNA demethylation
pathways that involve TET enzymatic machineries to convert 5-
methylcytosine to 5-hydroxylmethylcytosine. Tet3 expression is
dynamically regulated by synaptic activity and in turn effects ex-
citatory glutamatergic transmission by modulating the amount
of surface GluR1 at a transcriptional level (Yu et al., 2015). Timo-
thy Bredy (Queensland Brain Institute, Australia) talked about
RNA modiﬁcations, such as N6-methyladenosine, as a crucial
epigenetic mechanism in the ﬁne tuning of gene expression related
to adaptation.
The increasing amount of epigenetic modiﬁcations associated to
experience-dependent changes in the brain and linking epigenetic
alterations to development of neurological disorders provoked fer-
tile discussions regarding epigenetic modiﬁcations as potential tar-
gets for drug treatment. Jeffrey S. Ney (Janssen R&D/Johnson and
Johnson Innovation, Cambridge, MA, USA) portrayed the latest ad-
vances in the translational use of neuroepigenetic discoveries as
epigenetic therapies for brain disorders. It emerged that combining
genomic sequencing and expression data might represent a critical
strategy to better deﬁne the druggable epigenomes. Although
many of the epigenetic drugs hold great promises, such as HDAC
inhibitors as treatment for cognitive impairments, many challenges
are still unsolved, such as efﬁcient delivery through the blood-brain
barrier, safety, and tolerability for chronic treatments.
Molecular mechanisms
Experts in the ﬁeld of epigenetics presented their overview of
how diverse signaling transduction pathways affect behavioral
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Rosenfeld (University of California, San Diego, CA, USA) presented
his latest ﬁndings unraveling unexpected roles of enhancers as tran-
scription units, global roles of noncoding RNAs, and dynamic changes
in nuclear architecture inmodel systems relevant to cancer, develop-
ment, aging, and brain plasticity (Liu et al., 2014; Puc et al., 2015;
Skowronska-Krawczyk et al., 2014). His laboratory identiﬁed the
epigenomic signature underlying learning andmemory processes ac-
tivated by the Reelin signaling pathway, which is associated with
many neuropsychiatric disorders. The LRP8-Reelin-regulated en-
hancers orchestrate the transcriptional changes occurring duringhip-
pocampal associative learning and memory formation as a
consequence of a novel synapse-to-nucleus signaling involving the
γ-secretase–dependent release of the LRP8 intracellular domain
that serves as a messenger molecule to transduce synaptically gener-
ated signals in the nucleus (Telese et al., 2015).
Paolo Sassone-Corsi (University of California, Irvine, USA) illus-
trated a comprehensive picture of his long-lasting interest in
deciphering the epigenetic language of the circadian clock (Asher
and Sassone-Corsi, 2015). He presented his latest ﬁndings regarding
the oscillatory changes in gene expression as a strategy of epigenomic
regulation of the circadian rhythm. In the most inspiring part of his
talk, Paolo Sassone-Corsi described a novel link between energy me-
tabolism, epigenetics, and the circadian clock, showinghow the cellu-
lar metabolic processes in response to nutrients are intimately linked
to chromatin remodeling processes through cross-talk mechanisms
that involve NAD+-mediated metabolism, histone posttranslational
modiﬁcations, and enzymatic feedback loops mediated by the his-
tone deacetylases and histone methyltransferase (Aguilar-Arnal
et al., 2015).
The talk from IsabelleMansuy (Brain Research Institute, ETH Zurich,
Switzerland) focused on transgenerational epigenetics, a topic that has
recently attracted both interest and debate in the ﬁeld by proposing
epigenetic changes as a candidatemechanism to explain howan organ-
ism can transmit learned behaviors or traits to its offspring (Heard and
Martienssen, 2014). By using an experimental model of early traumatic
stress inmice, she provided evidence that traumatic events, such as un-
predictable maternal separation and maternal exposure to stress, can
strongly inﬂuence the behaviors of the offspring inducing depressive
behaviors and cognitive dysfunction across several generations (Gapp
et al., 2014b). She presented her latest ﬁndings indicating that these
phenomena are transmitted across generations thorough male sperms
and are associated with 3 potential nongenetic mechanisms: DNA
methylation of CpG islands of several genes, post-translational modiﬁ-
cations of histone tails, and altered expression of noncoding RNAs
(Gapp et al., 2014a). The challenge remains to provide evidence for
the causality link betweenepigenetic changes in spermcells andbehav-
ioral effects across generations.
Epigenomes
The need of ﬁnding the right intersections between traditional
approaches that have been instrumental in studying neuronal func-
tions, such as cellular and behavioral studies of various genetic
models, and ﬁne mechanistic insights provided by the plethora of
“omic” strategies was extensively covered by researchers at the fore-
front of this ﬁeld, which illustrated the rapid advances and unique
opportunities delivered by large-scale projects of relevance to the
neuroscience community (Romanoski et al., 2015).
Manolis Kellis (Broad Institute of MIT and Harvard) presented
some of the landmark achievements of the NIH Roadmap
Epigenomics Mapping Consortium, a public resource of reference
epigenomes that provide information on how key genomic regulato-
ry elements orchestrate gene expression patterns in 127 humantissues and cell types (Roadmap Epigenomics et al., 2015). This inte-
grative analysis was based on the global proﬁle of histone modiﬁca-
tions, DNA methylation, DNA accessibility, and RNA expression,
along with genome-wide association studies, linking disease and
trait-associated genetic variants to tissue-speciﬁc epigenomic
marks. By applying this strategy to a mouse model of Alzheimer dis-
ease, a team from Manolis Kellis and Li-Huei Tsai's groups demon-
strated that genetic variants associated with the disease are
enriched in evolutionary conserved regulatory enhancers that control
immune response genes linked to inﬂammation, but not neuronal
pathways (Gjoneska et al., 2015). These intriguing results suggest
that the immune functionsmight be themajor contributor to genetic
predisposition to Alzheimer disease, whereas the cognitive decline
could be linked to nongenetic environmental factors and identiﬁed
new factors that could become novel therapeutic targets.
Joseph R. Ecker delivered a retrospective that illustrated the great
advances in the exploration of mammalian methylomes based on
novel whole genome bisulﬁte sequencing assays developed in his
laboratory at The Salk Institute for Biological Studies, USA (Urich
et al., 2015). The genome-wide, base-resolution, DNA methylomes
proﬁling has been pivotal in studying thewidespread reconﬁguration
ofmethylation events occurringduringdevelopment of frontal cortex
(Lister et al., 2013). Joseph Ecker addressed a major challenge by an-
alyzing relatively homogenous populations of distinct neuronal sub-
types through an innovative puriﬁcation approach that allowed the
identiﬁcation of speciﬁc DNA methylation dynamics, which is key to
unravel the epigenetic mechanisms essential for maturation and
maintenance of distinct neuronal identities.
It was clear that proﬁling cell type–speciﬁc and disease state–spe-
ciﬁc epigenomic landscapes has a critical importance in understand-
ing of how epigenetic changes can contribute to or drive neuronal
identity and human disease.
Workshop: high-throughput sequencing for neuroepigenetics
Remarkable presentations were given during the highly informa-
tive workshop focused on the application of high-throughput
sequencing methods to address fundamental questions in neurosci-
ence. Particular emphasis was dedicated to the development of
novel computational frameworks to elucidate complex epigenomic
regulatory circuitries and to the epigenomic proﬁling of iPSCs as a
strategy for modeling brain diseases.
As part of the Roadmap Epigenomics Program, Michael J. Ziller
(Broad Institute of MIT and Harvard, USA) presented his extensive
work on uncovering the epigenomic plasticity during neuronal differ-
entiation (Ziller et al., 2015). By integrating DNAmethylation assays,
chromatin immunoprecipitation, and gene expression analysis, Mi-
chael Ziller identiﬁed the epigenetic footprint distinguishing each
cell state transition based on the progressive remodeling of the epige-
netic landscape. Each differentiation stage was linked to the combi-
natorial actions of speciﬁc transcription factors, which was revealed
by the novel computational framework (transcription factor epige-
netic remodeling activity) based on the assessment of DNA binding
motifs associated with distinct epigenetic states. This approach was
decisive to shed light on regulatory mechanisms of cell fate decisions
of neuronal development but also represents a general computation-
al strategy for the systematic discovery of the epigenomic changes in
a variety of biological systems.
The topic of modeling neurodevelopmental disorders by integrat-
ing epigenomic tools with iPSCs was presented byMatthew A. Lalli, a
graduate student from the University of California Santa Barbara,
USA. In his work, Matthew Lalli integrated global gene expression
proﬁling of Williams syndrome–induced pluripotent neurons with
genomic distribution by ChIP-seq of one of the genes deleted in
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that are likely to contribute to the cognitive and behavioral pheno-
types of the disorder, providing compelling evidence that the
epigenomic proﬁling of iPSCs represents a powerful tool formodeling
brain diseases and holds great promise for revealing cellular and be-
havioral phenotypes associated to patient-speciﬁc mutations.
Highlights from poster presentations
Exciting poster presentations covered all the aspect of
neuroepigenetics. Michael Corley, who was awarded with the
NIGMS Ancillary Training Program Scholarship for this conference,
presented a remarkable study carried out in the laboratory of Alika
Maunakea (Epigenomics Research Program of University of Hawai'i,
USA), whowas also a recipient of the Early-Career Investigator Travel
Award. Their work focused on the comparative DNA methylomic
analyses of the neurogenic subventricular zone from autism spec-
trum disorder–diagnosed postmortem brains, revealing substantial
autism spectrum disorder–speciﬁc alterations of DNA methylation,
with a stronger correlation with embryonic and neural stem cell–
speciﬁc methylation states, providing novel evidence in support of
the hypothesis that molecular alterations associated with autism
arise early in development.
On a similar topic, Eran Mukamel (University of California, San
Diego, USA) presented his work focused on novel genetic strategies
to isolate distinct cortical neuron cell types, such as parvalbumin-
expressing fast-spiking interneurons and vasoactive intestinal
peptide–expressing interneurons. Transcriptome and whole-
genome methylome proﬁling revealed cell type–speciﬁc patterns of
non-CGmethylation that covary with gene transcription across corti-
cal neuron types. His approach provides a valid tool to study the epi-
genetic regulatory networks necessary to develop and maintain
distinct neuronal identities.
Closing remarks and future perspectives
Apart from advancing our understanding of epigenetic mecha-
nisms of neuronal function anddysfunction, the symposiumcut across
boundaries ofmolecular biology and classical behavioral neuroscience
and provided a spirited discussion forum for promotion of cross-
disciplinary collaborations between investigators that normally may
not readily interact. Attendees of the symposium enthusiastically
agreed that this meeting provided an important context for the com-
munication and exchange of ideas that will have a major role in
inﬂuencing the direction of research in this ﬁeld. Moving forward,
the integration of innovative sequencing technologies, big data analy-
ses, disease modeling with iPSCs, and classical genetic and behavioral
studieswill provide a fertile ground for discoveries thatwill impact the
basic understanding of neuronal function and catalyze new diagnostic
and therapeutic strategies in disease.
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